Clinical Trial Update: A Study of CM326 in Subjects With Moderate to Severe Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CM326 in adults with moderate to severe asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CM326

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Moderate to Severe Asthma | Phase 2 | Status: UNKNOWN